BS-seq
An emerging field of research revealing RNA-modification-mediated regulation of gene expression and protein translation has shaped a new layer of biological complexity: the epitranscriptome. To date, more than 150 distinct RNA chemical modifications have been characterized. Most of these changes were originally described in highly abundant noncoding RNAs, including ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), and small nuclear RNAs (snRNAs), and have been implicated in several diseases, including cancer (Esteller and Pandolfi, 2017) , but recent advances in detection approaches have enabled their identification in messenger RNAs (mRNAs). This SnapShot summarizes the major breakthroughs in the field of epitranscriptomics, focusing on the internal mRNA modifications described to date in mammals: N The discovery of the N 6 -methyladenosine (m 6 A) eraser, FTO (Jia et al., 2011) , provided the first evidence of reversible posttranscriptional modifications in mRNAs and reinvigorated interest in mRNA modifications. Since then, complex networks of coordinated writers, erasers, and readers that determine the prevalence and distribution of mRNA modifications have been identified. After m 6 A deposition, carried out by the METTL3/METTL14 methyltransferase complex, functional consequences are orchestrated by a plethora of reader proteins.
From the first comprehensive transcriptome-wide mapping of m 6 A (Dominissini et al., 2012; Meyer et al., 2012) , technological improvements have allowed the global characterization of this and other modifications. Several of these approaches enrich for modified RNAs by immunoprecipitating RNAs or covalently bound RNA-methylase complexes, followed by next-generation sequencing (reviewed in Li et al., 2016) . Considering the strong influence of epitranscriptomic marks in fine-tuning gene expression and translation, it is not surprising that epitranscriptomic alterations have been linked to several syndromes and diseases, including cancer and neurological disorders. However, in most cases, a direct link with aberrant deposition patterns of the specific RNA modification has yet to be established.
Recent studies have also revealed the occurrence of N 6 ,2′-O-dimethyladenosine (m 6 A m ) at the 5′ end of transcripts. This reversible modification, erased by FTO, influences mRNA stability. Another modification affecting adenine is N1-methyladenosine (m 1 A), prevalent in nuclear mRNAs near translation start codons and also found in mitochondrial mRNA at CDS and 3′ UTRs. Current detection methods take advantage of the structural effects that the bulky modification causes during reverse transcription, leading to truncated reads and misincorporation patterns (reviewed in Li et al., 2016) . Similar to other modifications, its deposition is dynamically regulated by several proteins. Currently, its molecular function remains unknown, although its characteristic localization at 5′ UTRs could suggest a role in translation (Dominissini et al., 2016) . While altered activity or expression of its writers, erasers, or substrates is associated with diseases, whether altered m 1 A deposition patterns in mRNAs can cause similar pathological outcomes has yet to be revealed.
While 5-methylcytosine (m 5 C) occurrence has been long established in abundant noncoding RNAs, its presence in coding RNAs has only recently been shown. Detection approaches exploit the reactivity of unmethylated cytosines to bisulphite or enrich for methylated RNAs (reviewed in Li et al., 2016) . Initial transcriptome-wide profiles have identified hundreds to thousands of m 5 C sites in mRNAs. NSUN2 and DNMT2 deposit this modification (Frye and Blanco, 2016; Yang et al., 2017) , and while oxidation derivatives of m 5 C are detected in mRNA, a mammalian m 5 C eraser is yet to be found (reviewed in Frye and Blanco, 2016) . Only recently, Aly/REF export factor (reader) has been reported to bind m 5 C, indicating a role in nuclear export (Yang et al., 2017) . Physiologically, while mutations or altered expression of the writers are associated with intellectual disability and cancer, the pathological outcomes have been linked to deposition defects in tRNAs (Frye and Blanco, 2016) .
Occurrence of 3-methylcytosine (m 3 C) in mRNA-deposited by METTL8-has also been described. However, further molecular and functional significance remain undetermined. Uridine is also a target of modifications in a reaction catalyzed by pseudouridine synthases (PUSs) to generate pseudouridine (Ψ)-the most abundant RNA modification and the first to be discovered (1951) . In mRNAs, Ψ residues have been detected without positional bias in 5′ UTRs, coding sequences, and 3′ UTRs, with the latter being associated with increased mRNA stability. Ψ deposition is regulated in response to environmental signals (Carlile et al., 2014) . Ψ presence alters base-pairing interactions, affecting RNA structures, as well as mRNA coding.
Finally, although current epitranscritome studies have primarily focused on base modifications, the ribose can be methylated at the 2′ position to form 2′-O-methylated (Nm) nucleosides, recently identified in more than 2,000 protein-coding transcripts. Functionally, 2′-O-methylation in coding regions induces ribosome stalling by disrupting codon reading (Choi et al., 2018) .
Over the past decade, giant leaps have been made in the field of epitranscriptomics. Ongoing and future research to fill the gaps in epitranscriptomic knowledge guarantees more breakthrough discoveries in the coming years.
Abbreviations
For each particular modification, intense color is used when they are located in their most common position (5′ UTR, CDS, or 3′ UTR); &, m 1 A increases translation when occurring at 5′ UTR but decreases translation when occurring within the CDS; ¶, YTHDC1 and SRSF3 are involved in nuclear export; §, TET family encodes for DNA m 5 C demethylases, which also demethylate RNA in Drosophila; Aza-IP, 5-azacytidine-mediated RNA immunoprecipitation; BS-seq, Bisulphite sequencing; CMC, N-cyclohexyl-N'-(2-morpholinoethyl)carbodiimide; Library prep, library preparation; HT, high throughput; m 5 C-RIP, cytosine-5-methylated-RNA immunoprecipitation; miCLIP, methylation individual-nucleotide resolution crosslinking and immunoprecipitation; PA-m 6 A-seq, photo-crosslinking-assisted m6A sequencing; RISC, RNA-induced silencing complex; RT, retro-transcription; Seq, sequencing; tRNAF, tRNA fragment.
